Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-18

Clinical Trial Update: Cooperative Studies Program #563 - Prazosin and Combat Trauma PTSD [Phase 3]

View source ↗

Summary

Phase 3 Cooperative Studies Program #563 trial evaluating prazosin for combat-related post-traumatic stress disorder and sleep disorders has completed, with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prazosin (prazosin)

Snippet

Sponsor: VA Office of Research and Development | Conditions: PTSD, Sleep Disorders | Phase 3 | Status: COMPLETED | Results posted: 2014-06-18